Levest (Ethinylestradiol, Levonorgestrel)

Ethinylestradiol is a synthetic estrogen that suppresses the growth of ovarian follicles and stabilises the endometrial lining. In combination with levonorgestrel, it helps prevent the surge of luteinising hormone, thereby blocking ovulation and contributing to contraceptive efficacy.

The specific dosing regimen for Levest is determined by the prescribing healthcare professional. Typically, the medication is taken once daily at the same time each day, but the exact schedule and any missed‑dose instructions are provided by the prescriber.

Levest is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because it can cause fetal harm. Use while breastfeeding should be discussed with a healthcare provider, as hormonal contraceptives may affect milk production and infant exposure.

To order Levest, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Levest contains the standard dose combination of ethinylestradiol and levonorgestrel, which is comparable to many other combined oral contraceptives on the market. Its efficacy, safety profile, and side‑effect spectrum are similar to other products that use the same hormonal components, though individual tolerability may vary.

Levest tablets should be stored at ambient temperature, below 25 °C, in their original packaging. Protect them from excess moisture, heat, and direct sunlight. Keep the container tightly closed and out of reach of children.

Levest is taken orally as a tablet. The usual practice is to swallow one tablet each day, preferably at the same time each day, with or without food, as directed by the prescribing clinician.

The most serious risks include venous thromboembolism such as deep‑vein thrombosis, pulmonary embolism, and rare arterial events like stroke or myocardial infarction. Severe allergic reactions and liver disorders are also rare but potentially life‑threatening complications that require immediate medical attention.

Levest is contraindicated in women who are pregnant, have a history of thromboembolic disorders, uncontrolled hypertension, severe liver disease, known or suspected breast cancer, or who are smokers over the age of 35. It should also be avoided in individuals with known hypersensitivity to any component of the tablet.